<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02267304</url>
  </required_header>
  <id_info>
    <org_study_id>C13-02</org_study_id>
    <secondary_id>2013-003487-31</secondary_id>
    <nct_id>NCT02267304</nct_id>
  </id_info>
  <brief_title>Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Morphine and Naloxone on Motivation (MBBAnalgesic)</brief_title>
  <acronym>MBBAnalgesic</acronym>
  <official_title>Etude Comparative Monocentrique, randomisée, en Cross Over, en Double Aveugle, Contre Placebo, de l'Action de la Morphine et de la Naloxone Dans un modèle Cognitif de Gestion Des Efforts Physiques</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the current study is to examine the role of the opioïd system on the cognitive
      parameters of motivation. They are embedded in a conceptual framework of motivation that
      merges decision-making and reinforcement learning theories. Every action is conceived as path
      from one state to another. The different states are associated to different values (positive
      for rewards and negative for punishments), and the different actions to different costs
      (risk, effort and delay). The tasks are designed such that the sensitivity to the state and
      action parameters can be inferred by fitting computational models.The primary objective is to
      characterize the effect of Morphine 0,05mg/kg and Naloxone 10mg on cost accumulation slope,
      assessed in an effort management task, in which participants are asked to squeeze a hand grip
      during 30 seconds at varying level of effort in order to win monetary payoff. Secondary
      objectives are to characterize the effect of Morphine 0,05mg/kg and Naloxone 10mg on other
      cognitive parameters of motivation (assessed with a motivational battery that includes
      rating, choice and learning tasks).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cost Accumulation Slope (AU.)</measure>
    <time_frame>15 min after first placebo injection, 15 min after morphine (respectively naloxone) injection</time_frame>
    <description>The primary Outcome measure is the change in this parameter between the placebo condition and the morphine (respectively naloxone) condition.This parameter will be infered from the time spent in a effort period versus a rest period within trials of an effort managing task, for each subjects.</description>
  </primary_outcome>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>50 mL of sodium chloride (0,9%)</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine 0,05mg/kg</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Naloxone 10mg</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Man or woman, age ≥ 18 and &lt; 50

          -  Weight between 50 kg and 90 kg.

          -  No contraindication to effort

          -  No evolutive pathology that could interfere with the current study signed consent

          -  medical insurance (&quot;sécurité sociale&quot;)

        Exclusion Criteria:

          -  Age &lt; 18 or &gt; 50

          -  Smokers

          -  Person under curatorship, or guardianship, or with civil rights deprivation

          -  History of neurologic or psychiatric pathology

          -  Chronic or actual consumption of alcohol, or psychotropic drugs

          -  pregnancy, breastfeeding

          -  Woman of childbearing potential without effective contraception

          -  Liver failure

          -  Severe Cardiovascular Disorders

          -  Severe Cerebrovascular Discorders

          -  Morphine (or Naloxone) hypersensitivity/addiction

          -  Treatment contraindicated: morphine dérivatives, neuroleptics, barbiturate,
             benzodiazepine, anxiolytics, hypnotics, antidepressant, antihistamine,
             antihypertensives, beta blocker, baclofen, thalidomide

          -  Enzyme inducers, (rifampicine, …)

          -  Treatment that can interfere with the performance of the subject: beta2 adrenergic
             agonists, analgesics, corticosteroïds, anti-inflammatory drugs, …
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean -Christophe Corvol, MCU-PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>CIC Neurologie GH Pitié Salpêtrière</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CIC Neurologie GHPS</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Christophe Corvol, MCU-PH</last_name>
      <phone>0157274658</phone>
      <email>jccorvol@icm-institute.org</email>
    </contact>
    <contact_backup>
      <last_name>Mathias Pessiglione, PhD</last_name>
      <phone>0157274324</phone>
      <email>mathias.pessiglione@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 24, 2014</study_first_submitted>
  <study_first_submitted_qc>October 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2014</study_first_posted>
  <last_update_submitted>February 24, 2016</last_update_submitted>
  <last_update_submitted_qc>February 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>volunteers</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Naloxone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

